Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557. Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582. Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692. Podcast Sep 2021 Author Interview: What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?" Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Medical Education Aug 2016 Improving Pathologists’ Communication Skills Suzanne Dintzis, MD, PhD The communication training program at University of Washington Medical Center aims to develop best practices for effective pathology communication. AMA J Ethics. 2016;18(8):802-808. doi: 10.1001/journalofethics.2016.18.8.medu1-1608. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Medicine and Society Jul 2021 Invisibility of “Gender Dysphoria” Nicolle K. Strand, JD, MBE and Nora L. Jones, PhD Fostering transgender patients’ sense of agency should be a clinical and ethical priority. AMA J Ethics. 2021;23(7):E557-562. doi: 10.1001/amajethics.2021.557.
Art of Medicine Jul 2021 Wayfinding Brent R. Carr, MD This charcoal gesture drawing, inspired by a mid-adolescent nonbinary patient, investigates a caregiver’s and patient’s journey from despair to hope. AMA J Ethics. 2021;23(7):E582-583. doi: 10.1001/amajethics.2021.582.
Case and Commentary Sep 2021 What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard, MS Lack of training and lack of knowledge can adversely influence a patient’s clinical outcomes. AMA J Ethics. 2021;23(9):E692-696. doi: 10.1001/amajethics.2021.692.
Podcast Sep 2021 Author Interview: What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care? Jeffrey Bedard joins Ethics Talk to discuss his article: "What Should Patients Be Told About Device Representatives’ Roles at the Point of Surgical Care?"
Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Medical Education Aug 2016 Improving Pathologists’ Communication Skills Suzanne Dintzis, MD, PhD The communication training program at University of Washington Medical Center aims to develop best practices for effective pathology communication. AMA J Ethics. 2016;18(8):802-808. doi: 10.1001/journalofethics.2016.18.8.medu1-1608.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.